Schistosoma: Difference between revisions
From IDWiki
Schistosoma
(→) |
mNo edit summary |
||
Line 65: | Line 65: | ||
* Usually based on serology |
* Usually based on serology |
||
** Can cross-react with other helminth co-infections, including [[trichinosis]] and [[filariasis]] |
** Can cross-react with other helminth co-infections, including [[trichinosis]] and [[filariasis]] |
||
** Can remain positive and even fluctuate for years after cure[[CiteRef::yong2010lo]] |
|||
** Can remain positive and even fluctuate for years after cure<ref>Michelle K. Yong, FRACP and others, Long‐Term Follow‐Up of ''Schistosomiasis'' Serology Post‐Treatment in Australian Travelers and Immigrants, ''Journal of Travel Medicine'', Volume 17, Issue 2, 1 March 2010, Pages 89–93, https://doi.org/10.1111/j.1708-8305.2009.00379.x</ref> |
|||
==Management== |
==Management== |
Latest revision as of 14:15, 23 September 2024
Background
- Infection with a species of the genus Schistosoma
Microbiology
- Schistosoma mansoni: liver and gut
- Schistosoma haematobium: GU/pelvis
- Schistosoma japonicum: liver and gut
- Schistosoma mekongi: Mekong basin
Risk Factors
- Fresh water exposure in endemic countries
Epidemiology
- Seroprevalence in migrants by region of origin1
- Latin America and the Caribbean (20%; 9-34)
- Middle East and north Africa (6.4%; 0.3-19.5)
- Sub-Saharan Africa (24.1%; 16-33)
- South Asia (0%; 0-69)
- East Asia and the Pacific (5.4%; 2-10)
Clinical Manifestations
Swimmer's Itch
- Cercariae penetrate exposed skin and cause prickling sensation and occasionally urticaria, followed hours later by a macular rash
- Caused by schistosomes that do not cause systemic illness
- Common in Great Lakes region of North America, New England in the US, and other parts of North America and Europe
Katayama Fever
- Syndrome of acute schistosomiasis that follows 4 to 8 weeks (range 2 to 12 weeks), after the flukes have migrated, developed into adults, and have started producing eggs
- The syndrome represents a hypersensitivity reaction to the eggs produced by adult worms
- More common with Schistosoma japonicum and Schistosoma mansoni, and less common with Schistosoma haematobium
- Symptoms include abrypt onset of fever, chills, fatigue, headache, myalgias, abdominal pain, diarrhea, and occasionally bloody stool
- Most also develop cough, dyspnea, chest pain, and diffuse infiltrates on chest x-ray
- Lung nodules contain granulomas around eggs
- Hepatomegaly, splenomegaly, and lymphadenopathy are common
- Eggs may not be seen in stool until later in the course of the disease
- Symptoms usually resolve within 2 to 10 weeks
- Can involve symptoms anywhere the worms migrate and deposit eggs: CNS, genital tract, and skin
- However, an induced small-vessel vasculitis can also cause neurological symptoms
Chronic Schistosomiasis
- Can be asymptomatic or paucisymptomatic
- Chronic granulomatous inflammation causes weight loss, anemia, stunted growth
- Eosinophilia is common
Investigations
- Labs
- CBC, showing eosinophilia
- Schistosoma serology (only positive 6 weeks after infection)
- Egg detection in stool, urine, semen, or tissue biopsy
- Imaging
- Eggs can cause granulomatous disease in various organs
- Bladder polyps and obstruction may be seen on ultrasound
Diagnosis
- Usually based on serology
- Can cross-react with other helminth co-infections, including trichinosis and filariasis
- Can remain positive and even fluctuate for years after cure2
Management
- Acute
- Praziquantel 40mg/kg given over one day split into 3 doses
- Chronic
- Praziquantel 20-40 mg/kg or 40-60 mg/kg (if at risk for S. japonica)
- Given over one day split into 3 doses
- May be repeated 6 weeks later, though this practice is not universal
- No role for test-of-cure serology
Prognosis
- Increased risk of squamous cell carcinoma, which increase with young age at infection, duration of infection, high burden of infection, and bladder wall fibrosis
References
- ^ Archana Asundi, Alina Beliavsky, Xing Jian Liu, Arash Akaberi, Guido Schwarzer, Zeno Bisoffi, Ana Requena-Méndez, Ian Shrier, Christina Greenaway. Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis. The Lancet Global Health. 2019;7(2):e236-e248. doi:10.1016/s2214-109x(18)30490-x.
- ^ Michelle K. Yong, Carolyn L. Beckett, Karin Leder, Beverley A. Biggs, Joseph Torresi, Daniel P. O’Brien. Long‐Term Follow‐Up ofSchistosomiasisSerology Post‐Treatment in Australian Travelers and Immigrants. Journal of Travel Medicine. 2010;17(2):89-93. doi:10.1111/j.1708-8305.2009.00379.x.